{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2014"],"condition":["Adenocarcinoma","Endometrial Cancer","Lung cancer","Colorectal cancer","Fallopian Tube Cancer","Breast cancer","Endometrial Neoplasms","Bladder cancer","Esophagus cancer","Ovarian Cancer","Small cell lung cancer","Head and Neck cancer","Fallopian Tube Neoplasms","Pancreatic cancer","Non-small cell lung cancer","Advanced solid tumors","Carcinoma, Ovarian Epithelial","Ovarian Neoplasms","Gastric cancer","Prostate cancer","Solid Tumors"],"disease":["Adenocarcinoma","Endometrial Cancer","Lung Cancer","Small Cell Lung Cancer","Advanced Solid Tumors","Fallopian Tube Cancer","Colorectal Cancer","Bladder Cancer","Pancreatic Cancer","Endometrial Neoplasms","Breast Cancer","Ovarian Cancer","Esophagus Cancer","Fallopian Tube Neoplasms","Non-small Cell Lung Cancer","Carcinoma, Ovarian Epithelial","Gastric Cancer","Prostate Cancer","Head And Neck Cancer","Ovarian Neoplasms","Solid Tumors"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2176096"],"location":["United States"],"study_start_month":["10"],"keyword":["Liposomal doxorubicin","Liver cancer","Serous tumor","Granulosa tumor","Clear Cell tumor","Kidney cancer","Hepatobiliary cancer","Doxorubicin","Skin cancer"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors","description":"This is a Phase I study to test the safety, pharmacokinetics and effectiveness of STM 434 alone, or in combination with liposomal doxorubicin, in patients with ovarian cancer or other advanced solid tumors.","dates":{"creation":"2014-10-15"},"accession":"2176096","cross_references":{"ClinicalTrials___gov":["NCT02262455"]}}